NanoRegMed

NanoRegMed creates new nanomaterials to bring your innovations to the future. We produce reduced graphene oxide and functionalised graphene oxide with superior levels of functionalisation certified by the UK National Physical Laboratory. NanoRegMed can act as an R&D partner on projects and grant applications globally and in a variety of fields. Goodfellow and NanoRegMed have announced a partnership facilitating the supply by Goodfellow of NanoRegMed's materials. Based in the London BioScience Innovation Centre, NanoRegMed creates and brings to market innovative materials and components for materials for a wide variety of applications.We are commercialising a new family of biodegradable and non-biodegradable graphene-based nanocomposites, Hastalex® and BioHastalex® that help repair or replace damaged or missing organs and are superior to any other material available today. Corporate Livewire Innovation & Excellence Awards have announced that NanoRegMed is their Biotech company of the year. Southern Enterprise Awards have awarded NanoRegMed the Most Innovate Biotechnology Company in the UK 2021 award. Hana worked in financial services for over 15 years and held senior positions in leading global investment banks.